Mirabaud & Cie’s Merck MRK Stock Holding History

Mirabaud & Cie’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,059	Closed	-$1.5M	–	63
2024 Q4	$1.5M	Sell	15,059 -22,470	-60%	-$2.32M	0.48%	34
2024 Q3	$4.26M	Sell	37,529 -6,741	-15%	-$801K	1.23%	19
2024 Q2	$5.48M	Sell	44,270 -3,085	-7%	-$397K	1.85%	17
2024 Q1	$6.25M	Sell	47,355 -4,869	-9%	-$600K	2.2%	15
2023 Q4	$5.69M	Buy	+52,224	New	+$5.42M	1.9%	19

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirabaud & Cie's MRK Position: Q1 2025 in Review

Mirabaud & Cie sold out of Merck (MRK) in Q1 2025, closing a stake of 15,059 shares — an estimated $1.5M sold.

Mirabaud & Cie first reported a position in MRK in Q4 2023 and held it in 5 quarters. The position peaked at $6.25M in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Mirabaud & Cie reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Mirabaud & Cie sold 15,059 Merck shares in Q1 2025, an estimated $1.5M.
Mirabaud & Cie first reported a position in Merck in Q4 2023 and held it in 5 quarters.
Mirabaud & Cie's Merck position peaked at $6.25M in Q1 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Mirabaud & Cie's 13F filing for Q1 2025, filed 9 May 2025.